Meeting
2016 ASCO Annual Meeting
Feasibility and efficacy of concomitant chemoradiation (Ch-RT) in the management of newly diagnosed elderly glioblastoma (GB) patients: Results from the GLIOCAT study.
Authors
Maria Martinez-Garcia
Medical Oncology, Hospital del Mar, Barcelona, Spain
Maria Martinez-Garcia , Estela Pineda , Sonia del Barco , Natalia Garcia , Eugenia Verger , Carlos Mesia , Anna Estival , Oscar Gallego , Miguel J. Gil Gil , Rafel Fuentes , Jordi Craven , Salvador Villà , Núria de la Iglesia , Francesc Alameda , Cristina Carrato , Teresa Ribalta , Jose Maria Velarde , Carmen Balana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2045)
DOI
10.1200/JCO.2016.34.15_suppl.2045
Abstract #
2045
Poster Bd #
232
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM).
First Author: Peijing Li
Poster
2014 ASCO Annual Meeting
Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolomide in newly diagnosed, MGMT-non-methylated glioblastoma patients.
First Author: Ulrich Herrlinger
Poster
2012 ASCO Annual Meeting
A randomized, double‑blind, controlled phase IIb study of the safety and efficacy of ICT‑107 in newly diagnosed patients with glioblastoma multiforme following resection and chemoradiation.
First Author: Elma S. Hawkins
Poster
2022 ASCO Annual Meeting
Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
First Author: John S. Bomalaski